Key result
Wireless capsule endoscopy performed in patients with implantable cardiac devices resulted in zero device-related complications or cardiac abnormalities during the procedure and 30-day follow-up.
Why the study?
Wireless capsule endoscopy is increasingly used for gastrointestinal bleeding, but data evaluating its safety in patients with implantable cardiac devices are limited.
Does wireless capsule endoscopy cause adverse cardiac outcomes or device interference in patients with implantable cardiac devices?
Cohort (n=83)
No
Does wireless capsule endoscopy cause adverse cardiac outcomes or device interference in patients with implantable cardiac devices?
Wireless capsule endoscopy appears safe and free from electromagnetic interference in patients with implantable cardiac devices, including LVADs, challenging current FDA relative contraindications.
May support capsule endoscopy in device patients without apparent interference; leaves open need for randomized confirmation before practice change.
BACKGROUND AND AIM: Wireless capsule endoscopy (WCE) has become an increasingly utilized imaging modality for the evaluation of gastrointestinal bleeding. There is a paucity of data evaluating the safety and use of WCE in patients with implantable cardiac devices. METHODS: A retrospective chart review of all patients who had a WCE at Loyola University Medical Center in Maywood, IL, USA completed between January 2007 and December 2016 identified patients with internal cardiac devices and obscure gastrointestinal bleeding. Patient WCE footage was viewed in its entirety before creating a final report to ensure no gaps in footage and video quality. RESULTS: No patient complaints were documented during the 8-h procedure duration, and there were no cardiac abnormalities noted on telemetry. There were no device-related complications documented in the 30-day postprocedure time period. Postprocedure analysis of the WCE recordings demonstrated no interference in WCE image quality (loss of images or gaps in video) or duration. CONCLUSIONS: There is no significant interference between WCE and implantable cardiac devices, and it appears to be safe to use.
No takes yet. Share an insight, caveat, or question.
Kasia et al. (2019) conducted a cohort in Obscure gastrointestinal bleeding in patients with implantable cardiac devices (n=83). Wireless capsule endoscopy was evaluated on Adverse cardiac outcomes or device-related complications during the procedure and up to 30 days postprocedure. Wireless capsule endoscopy performed in patients with implantable cardiac devices resulted in zero device-related complications or cardiac abnormalities during the procedure and 30-day follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: